Clinical trial
Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients…
NCT00006122 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00006122 |
|---|---|
| Title | Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia |
| Official title | Gemtuzumab Ozogamicin (CMA-676) Followed or Not by Intensive Chemotherapy as Initial Treatment for Elderly Patients With Acute Myeloid Leukemia: An EORTC-LG Pilot Phase II Study |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug |
| Interventions | cytarabine, etoposide, gemtuzumab ozogamicin, idarubicin, mitoxantrone hydrochloride |
| Enrollment | 106 |
| Start date | Jun 1, 2000 |
| Primary completion | Jan 1, 2002 |
| First posted | Feb 16, 2004 |
| Last update posted | Jul 16, 2012 |
| Countries | Austria, Belgium, Croatia, France, Germany, Italy, Netherlands |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: